find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
5
Clinical Trials
Lung Cancer Clinical Trials
III
Accepting Patients
nct/study# NCT03906071 / 516-005
A Randomized Phase 3 Study Of Sitravatinib In Combination With Nivolumab Versus Docetaxel In Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On Or After Platinum-Based Chemotherapy In Combination With Checkpoint Inhibitor Therapy
Learn More
Lung Cancer Clinical Trials
N/A
Accepting Patients
nct/study# NCT04894591 / JZP712-402 EMERGE
Phase IV Observational Study To Collect Safety And Outcome Data In Real-World Setting In Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca (EMERGE 402)
Learn More
Lung Cancer Clinical Trials
II
Accepting Patients
nct/study# NCT04863248 / G1T28-210
A Phase 2 Randomized, Double-Blind, Clinical Trial Of Trilaciclib Versus Placebo In Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Treated With Docetaxel In The 2nd/3rd Line Setting (PRESERVE 4)
Learn More
Lung Cancer Clinical Trials
II
Active
nct/study# NCT04919811 / AB-106-G208
Taletrectinib In ROS1 Positive Lung Cancer Phase 2 Global Study
Learn More
Lung Cancer Clinical Trials
II
Accepting Patients
nct/study# NCT04623775 / CA224-104
A Study Of Relatlimab Plus Nivolumab In Combination With Chemotherapy Vs. Nivolumab In Combination With Chemotherapy In Participants With Stage IV Or Recurrent NSCLC
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.